Resuscitation with increasing doses of diaspirin crosslinked hemoglobin in swine.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Artificial cells, blood substitutes, and immobilization biotechnology

• Publication date

  1996-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/10731199609117440PMID 8879422
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Resuscitation with Diaspirin Crosslinked Hemoglobin in a pig model of hemorrhagic shock.

  1995cited by this paper
• Characterization of the hemodynamic response to intravenous diaspirin crosslinked hemoglobin solution in rats.

  1994cited by this paper
• Prazosin blocks the pressor but not the regional circulatory effects of diaspirin crosslinked hemoglobin.

  1994cited by this paper
• Role of adrenergic mechanisms in the pressor effect of diaspirin cross-linked hemoglobin.

  1994cited by this paper
• Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin.

  1993cited by this paper
• Hemodilution with Oxyhemoglobin Mechanism of Oxygen Delivery and Its Superaugmentation with a Nitric Oxide Donor (Sodium Nitroprusside)

  1993cited by this paper
• Use of base deficit to compare resuscitation with lactated Ringer's solution, Haemaccel, whole blood, and diaspirin cross-linked hemoglobin following hemorrhage in rats.

  1993cited by this paper
• A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin.

  1993cited by this paper
• Effect of a single replacement of one of Ringer lactate, hypertonic saline/dextran, 7g% albumin, stroma-free hemoglobin, o-raffinose polyhemoglobin or whole blood on the long term survival of unanesthetized rats with lethal hemorrhagic shock after 67% acute blood loss.

  1992cited by this paper
• Increased plasma O2 solubility improves O2 uptake of in situ dog muscle working maximally.

  1992cited by this paper
• Cross-linked hemoglobin solution as a resuscitative fluid after hemorrhage in the rat.

  1991cited by this paper
• Synthesis of Wild Type and Mutant Human Hemoglobins in Saccharomyces cerevisiae

  1991cited by this paper
• Cross-linked hemoglobin solution as a resuscitative fluid after hemorrhage in the rat.

  1991cited by this paper
• Intravascular retention and renal handling of purified natural and intramolecularly cross-linked hemoglobins.

  1991cited by this paper
• Base deficit as a sensitive indicator of compensated shock and tissue oxygen utilization.

  1991cited by this paper
• Nitric oxide: physiology, pathophysiology, and pharmacology.

  1991cited by this paper
• Filtration-assisted exchange transfusion using alpha alpha Hb, an erythrocyte substitute.

  1991cited by this paper
• Conjugated Human Hemoglobin as a Physiological Oxygen Carrier - Pyridoxalated Hemoglobin Polyoxyethylene Conjugate (PHP)

  1990cited by this paper
• Hemodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement.

  1990cited by this paper
• Reexamination of the polymerization of pyridoxylated hemoglobin with glutaraldehyde

  1990cited by this paper
• Base deficit as a guide to volume resuscitation.

  1988cited by this paper
• Toxicity of polymerized hemoglobin solutions.

  1988cited by this paper
• Mechanisms of toxicity of hemoglobin solutions.

  1988cited by this paper
• HbXL99 alpha: a hemoglobin derivative that is cross-linked between the alpha subunits is useful as a blood substitute.

  1987cited by this paper
• Isolation and characterization of a new hemoglobin derivative cross-linked between the alpha chains (lysine 99 alpha 1----lysine 99 alpha 2).

  1986cited by this paper
• Alternate sources and substitutes for therapeutic blood components.

  1985cited by this paper
• Chlorpromazine as a substitute for ortho-dianisidine and ortho-tolidine in the determination of chlorine, hemoglobin, and peroxidase activity.

  1974cited by this paper

• Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics

  2013cites this paper
• HBOCs and Cardiac Integrity

  2013cites this paper
• Functional heterogeneity of oxygen supply with blood and hemoglobin-based oxygen carriers in porcine models of hemorrhagic shock

  2012cites this paper
• Effect of maleimide-polyethylene glycol hemoglobin (MP4) on hemodynamics and acid-base status after uncontrolled hemorrhage in anesthetized swine: comparison with crystalloid and blood.

  2007cites this paper
• Effects of diaspirin crosslinked hemoglobin infusion in treadmill-exercised swine

  2006cites this paper
• Hemodynamic response and oxygen transport in pigs resuscitated with maleimide-polyethylene glycol-modified hemoglobin (MP4).

  2004cites this paper
• Hemoglobin-based oxygen carrier provides heterogeneous microvascular oxygenation in heart and gut after hemorrhage in pigs.

  2003cites this paper
• Effects of diaspirin cross-linked hemoglobin (DCLHb) during and post-CPR in swine.

  2001cites this paper
• Die periphere und zentrale Gewebeoxygenierung unter akuter isovolämer Hämodilution mit der bovinen Hämoglobinlösung HBOC-201 im Vergleich zu Hydroxyäthylstärke im Tiermodell

  2001cites this paper
• Hemoglobin Solutions as Blood Substitutes

  2000cites this paper
• Comparison of various hemoglobin polyoxyethylene conjugate solutions as resuscitative fluids after hemorrhagic shock.

  2000cites this paper
• Hemoglobin solutions as blood substitutes.

  2000cites this paper
• New hemoglobin substitutes.

  1999cites this paper
• Blood substitutes: Haemoglobin therapeutics in clinical practice

  1999cites this paper
• Effect of alpha(alpha)-cross-linked hemoglobin and pyridoxalated hemoglobin polyoxyethylene conjugate solutions on gastrointestinal regional perfusion in hemorrhagic shock.

  1998cites this paper
• Pulmonary hypertension and systemic vasoconstriction may offset the benefits of acellular hemoglobin blood substitutes.

  1997cites this paper
• Applications of site‐specific chemical modification in the manufacture of biopharmaceuticals: I. An overview

  1997cites this paper